Overview PreAsthmaControl (PAC) Status: Completed Trial end date: 2004-12-01 Target enrollment: Participant gender: Summary The purpose of this study is to investigate the ability of budesonide, given during episodes of troublesome lung symptoms to reduce further symptoms in infants and young children at risk of developing asthma Phase: Phase 4 Details Lead Sponsor: AstraZenecaTreatments: Budesonide